[rscho]

I am well aware of the downsides of metformin since someone ends up in my ER (and sometimes dies) because of it most weeks. So you'll excuse me if an off-label and very new potential indication is not an immediate go for me. When we want to open a new indication for a particular drug, evaluation of the risk-benefit ratio for this particular indication has to be performed. There are many factors at play and results are completely unpredictable.

As for the rest no, I'm all for pop-science because it's what stimulates the interest of the masses. The problem in my eyes is more that academic medical studies available to the wider public are akin to a very sharp saw, and people will get cut if they don't know what they're doing.

[staticassertion]

Yeah I'd recommend you open up with information like that in the future, just right off the bat. It's a lot more interesting and at least somewhat useful.